Assessing the impact of COVID-19 measures on COPD management and patients: a simulation-based decision support tool for COPD services in the UK

Objectives To develop a computer-based decision support tool (DST) for key decision makers to safely explore the impact on chronic obstructive pulmonary disease (COPD) care of service changes driven by restrictions to prevent the spread of COVID-19.Design The DST is powered by discrete event simulat...

Full description

Bibliographic Details
Published in:	BMJ Open
Main Authors:	Reda Lebcir, Usame Yakutcan, Eren Demir
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2022-10-01
Online Access:	https://bmjopen.bmj.com/content/12/10/e062305.full

Similar Items

Research-informed decision-making for empowering integrated care system development: Co-creating innovative solutions to facilitate enhanced service provision.
by: Eren Demir, et al.
Published: (2025-01-01)

A statistical assessment of association between meteorological parameters and COVID-19 pandemic in 10 countries
by: Shola Adeyemi, et al.
Published: (2020-07-01)

Predicting COPD Readmission: An Intelligent Clinical Decision Support System
by: Julia López-Canay, et al.
Published: (2025-01-01)

Renaming COPD exacerbations: the UK respiratory nursing perspective
by: Christine Mwasuku, et al.
Published: (2021-09-01)

Validation of ACCESS: an automated tool to support self-management of COPD exacerbations
by: Boer LM, et al.
Published: (2018-10-01)

COPD Exacerbations Before and During COVID-19 in France, Germany, Italy, the UK and the US
by: Martinez FJ, et al.
Published: (2024-06-01)

Seroprevalence of Bordetella pertussis in patients with COPD in a UK cohort
by: Hollian Richardson, et al.
Published: (2025-06-01)

Circulating liver function markers and the risk of COPD in the UK Biobank
by: Wencong Du, et al.
Published: (2023-03-01)

Cost-effectiveness of physical activity in the management of COPD patients in the UK
by: Ramos M, et al.
Published: (2019-01-01)

Disability related to COPD tool (DIRECT): towards an assessment of COPD-related disability in routine practice
by: Aguilaniu B, et al.
Published: (2011-07-01)

Medical decision in COPD: the evidence-based history
by: António Duarte-de-Araújo, et al.
Published: (2021-07-01)

Pre-COPD: a New Advance in COPD
by: BAI Yahu, GAO Shenghan, JI Siyu, SHANG Jinyu, DONG Yanchun, NING Kang
Published: (2023-01-01)

Sarcopenia in COPD: relationship with COPD severity and prognosis
by: Tatiana Munhoz da Rocha Lemos Costa, et al.
Published: (2015-10-01)

Lung volume reduction eligibility in patients with COPD completing pulmonary rehabilitation: results from the UK National Asthma and COPD Audit Programme
by: Michael C Steiner, et al.
Published: (2020-11-01)

Muscle loss phenotype in COPD is associated with adverse outcomes in the UK Biobank
by: Amy H. Attaway, et al.
Published: (2024-04-01)

The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK
by: Brusselle G, et al.
Published: (2015-10-01)

Validity and interpretation of spirometric recordings to diagnose COPD in UK primary care
by: Rothnie KJ, et al.
Published: (2017-06-01)

COPD Assessment Test as a Screening Tool for Anxiety and Depression in Stable COPD Patients: A Feasibility Study
by: Meishan Liu, et al.
Published: (2023-12-01)

HCKing COPD: unveiling the role of HCK in COPD pathogenesis
by: Richard Y. Kim, et al.
Published: (2025-05-01)

Unravelling young COPD and pre-COPD in the general population
by: Borja G. Cosío, et al.
Published: (2023-02-01)

Blurred lines. Eosinophilic COPD: ACOS or COPD phenotype?
by: C.C. Loureiro
Published: (2016-09-01)

Chest CT Airway and Vascular Measurements in Females with COPD or Long-COVID
by: Harkiran K. Kooner, et al.
Published: (2024-12-01)

Economic Analysis of New Single-Inhaler Triple Therapies in Patients with COPD in the UK
by: Cai R, et al.
Published: (2025-08-01)

Differences in severe exacerbations rates and healthcare utilisation in COPD populations in the UK and France
by: Jennifer K Quint, et al.
Published: (2022-08-01)

Is single-inhaler triple therapy for COPD cost-effective in the UK? The IMPACT trial
by: Alan Martin, et al.
Published: (2022-02-01)

Cost-effectiveness analysis of a single-inhaler triple therapy for COPD in the UK
by: Elisabeth Fenwick, et al.
Published: (2021-03-01)

COPD: Are we using all the tools we have?
by: A. Araújo
Published: (2016-05-01)

Disease awareness in patients with COPD: measurement and extent
by: Baiardini I, et al.
Published: (2018-12-01)

Biologics in COPD
by: Ana L. Kersul, et al.
Published: (2024-04-01)

Indices and COPD
by: Howard Peter
Published: (2010-06-01)

Comorbidities of COPD
by: Arnaud Cavaillès, et al.
Published: (2013-12-01)

Pharmacotherapies for COPD
by: Stan Ejiofor, et al.
Published: (2013-04-01)

Epidemiology of COPD
by: C. Raherison, et al.
Published: (2009-12-01)

Imaging and COPD
by: Bruno Hochhegger
Published: (2015-12-01)

Exacerbations of COPD
by: Christian Viniol, et al.
Published: (2018-03-01)

COPD and nutrition
by: Caszo Brinnell, et al.
Published: (2006-01-01)

Mepolizumab for Eosinophilic COPD: What Matinee Adds to COPD Management?
by: Isabel Maria Alcázar-Martínez, et al.
Published: (2025-07-01)

Do Antidepressants Worsen COPD Outcomes in Depressed Patients with COPD?
by: Alan G. Kaplan
Published: (2024-11-01)

Chronic obstructive pulmonary disease (COPD) and COPD-like phenotypes
by: Spyridon Fortis, et al.
Published: (2024-04-01)

Risk factors for cardiovascular disease in patients with COPD: mild-to-moderate COPD versus severe-to-very severe COPD
by: Laura Miranda de Oliveira Caram, et al.